EIDOS THERAPEUTICS, INC.
CIK 0001731831
Revenue (TTM)
$26.69M
Q3 Oct 2020
Net Income (TTM)
−$74.92M
+7.1% YoY
Q3 Oct 2020
EPS Diluted (TTM)
−$0.51
−383.3% YoY
Q3 Oct 2020
Gross Margin
90.6%
Q3 Oct 2020
Operating Margin
-278.3%
Q3 Oct 2020
Net Margin
-280.7%
Q3 Oct 2020
Free Cash Flow (TTM)
−$31.88M
Q3 Oct 2020
Cash
$147.33M
Q3 Oct 2020
Total Debt
$16.73M
Q3 Oct 2020
Shares Outstanding
38.66M sh
Q3 Oct 2020
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.